Search - tctmd.com

Displaying 441 - 460 of 607

Sort: Relevancy | Date

Presentation ARCH 2019

Structural Heart Disease - A Peek into the Future

Presenter: Ian T. Meredith

April 11, 2019

Podcast Rox Heart Radio

A Roundtable With Publishers - What Are Journals Looking for?

April 10, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Industry News

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

April 10, 2019

News Daily News

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

Yael L. Maxwell

April 09, 2019

News Daily News

Race, Socioeconomic Status Gaps in Revascularization Rates Persist Among Women With ACS

Yael L. Maxwell

April 05, 2019

Podcast TCTMD Talking Points

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

April 03, 2019

News Daily News

AHA Statement on MINOCA Provides a Standard Definition, Clinical Care Algorithms

Yael L. Maxwell

April 03, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Featured Fellow

Philipp Wiesner, MD

Yael L. Maxwell

April 01, 2019

Presentation SIF 2019

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Presenter: Brij Maini

March 30, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

Presentation SIF 2019

Women & Heart Disease

Presenter: Danielle Stearns

March 29, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Podcast Heart Sounds

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Daily News

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Todd Neale

March 25, 2019

Advertisement

Structural Heart Disease - A Peek into the Future

A Roundtable With Publishers - What Are Journals Looking for?

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

Race, Socioeconomic Status Gaps in Revascularization Rates Persist Among Women With ACS

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

AHA Statement on MINOCA Provides a Standard Definition, Clinical Care Algorithms

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Philipp Wiesner, MD

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

Women & Heart Disease

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Top Stories in Cardiology: March 2019

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content